In support of this hypothesis, a report suggested that reduced VDAC1 expression in VDAC1+/− mice decreased the mRNA expression levels of AD-related genes, including βAPP, Tau, PS1, PS2 and BACE1, compared with their expression levels in VDAC1+/+ mice [159]. The gene discussed is MAPT; the disease is Alzheimer disease.